Contineum Therapeutics Balance Sheet (2023-2026) | CTNM

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Accumulated Depreciation (Quarter) 1.48M1.72M
Assets
Current Assets
Cash & Equivalents (Quarter) 15.53M16.26M77.23M40.89M21.94M22.47M20.78M42.63M75.60M20.16M
Prepaid Assets (Quarter) 2.52M1.80M1.67M1.23M1.63M1.42M1.35M2.52M5.02M6.64M
Current Assets (Quarter) 127.71M119.71M220.32M215.14M206.39M192.13M176.84M184.93M267.92M252.96M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 0.68M0.76M0.80M0.89M0.99M0.89M0.86M0.88M0.83M1.06M
Other Non-Current Assets (Quarter) 1.28M2.62M0.00M0.00M0.00M0.00M0.19M0.27M0.26M0.31M
Non-Current Assets (Quarter) 2.68M3.85M1.03M0.89M6.46M6.13M6.05M5.92M8.72M8.38M
Assets (Quarter) 130.39M123.56M221.35M216.03M212.85M198.26M182.89M190.85M276.64M261.35M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 0.64M0.57M0.73M1.40M1.81M3.65M2.00M0.79M1.02M1.50M
Payables (Quarter) 0.64M0.57M0.73M1.40M1.81M3.65M2.00M0.79M1.02M1.50M
Accumulated Expenses (Quarter) 4.38M0.96M1.40M2.18M6.71M1.19M1.77M2.81M6.39M2.86M
Other Accumulated Expenses (Quarter) 0.10M0.03M0.05M0.08M0.12M2.48M0.11M0.05M
Current Leases (Quarter) 0.46M0.47M0.48M0.61M1.45M1.46M1.47M1.48M2.34M2.30M
Total Current Liabilities (Quarter) 5.48M6.23M3.74M5.81M9.97M8.95M7.21M6.36M9.74M6.66M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter) 192.62M192.62M
Operating Leases (Quarter) 0.11M0.11M0.11M4.81M4.55M4.28M4.02M8.25M6.95M
Other Non-Current Liabilities (Quarter) 0.11M0.23M
Total Non-Current Liabilities (Quarter) 5.59M6.34M3.85M5.81M14.78M
Total Liabilities (Quarter) 97.46M55.43M61.15M5.70M6.57M3.85M5.81M14.78M13.50M11.50M10.38M15.65M11.31M
Shareholder's Equity
Common Equity (Quarter) -97.46M-55.43M-61.15M-67.94M-75.63M217.50M210.23M198.07M184.77M171.39M180.47M260.99M250.04M
Shareholder's Equity (Quarter) -97.46M-55.43M-61.15M-67.94M-75.63M217.50M210.23M198.07M184.77M171.39M180.47M260.99M250.04M
Liabilities and Shareholders Equity (Quarter) 130.39M123.56M221.35M216.03M212.85M198.26M182.89M190.85M276.64M261.35M
Retained Earnings (Quarter) -75.14M-83.56M-92.57M-102.80M-117.40M0.17M-149.40M-162.22M-177.38M-0.25M
Shares Outstanding (Quarter) 2.27M2.32M15.91M15.91M18.99M25.74M6.73M25.87M25.92M29.18M37.32M32.72M